Navigation Links
New gene-silencing pathway found in plants
Date:11/17/2008

tly.

The Space between Genes

Using Arabidopsis thaliana, the "laboratory rat" of the plant world, Pikaard and his colleagues carried out a series of genetic tests to pinpoint where in the genome Pol V was getting down to business.

Following a hunch, postdoctoral scholar Andrzej Wierzbicki decided to take a closer look at the stretches of DNA that lie between genes, the so-called intergenic regions. Biologists have long been baffled by this alleged "junk DNA" because transcription seems to occur here, and just about everywhere, genes and junk alike.

"This is a hot topic in genetics right now," says Pikaard. "It looks like not just the genes are getting transcribed, but pretty much all of the DNA is getting transcribed. And why? What's the purpose of all this transcription?"

Wierzbicki's instincts paid off. Using high levels of PCR amplification, he determined that Pol V was indeed hard at work within the intergenic region. In this space between genes, Pol V makes noncoding RNA transcripts that he and Pikaard think bind with the siRNAs generated by Pol IV. By acting as a scaffold for these siRNAs, the Pol V transcripts enable silencing of adjacent, virus-derived genes such as retrotransposons (jumping genes) that can be detrimental if activated. Pikaard and colleagues were able to confirm that both Pol IV and Pol V are necessary for silencing by examining mutations that knock out, or disable, the different genes coding for the polymerases.

'Junk' no more

This research adds to a growing body of evidence suggesting that "junk DNA" is in fact a functional part of the genome, since transcription of the intergenic regions is necessary to keep potentially harmful genes turned off. In addition, Pikaard and his colleagues have resolved a paradox that has recently puzzled geneticists: the need for transcription in order to transcriptionally silence the same region. In the case of
'/>"/>

Contact: Craig Pikaard
pikaard@wustl.edu
314-935-7569
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Class of antibiotics can enhance gene-silencing tool
2. Research uncovers new steps on pathway to enlarged heart
3. Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability
4. Breast cancer treatment resistance linked to signaling pathway
5. Combining advanced medical and information technologies offers pathway to lower health care costs
6. USC researchers identify alternate pathway that leads to palate development
7. Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway
8. A new cellular pathway linked to cancer is identified by NYU researchers
9. Gladstone scientists create Wikipathways to foster research collaboration
10. MIT probe may help untangle cells signaling pathways
11. Study identifies brain pathway that shuts down seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smo
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 1Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 3New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 1New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 2New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 3American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 1American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 2
...dence suggesting an alternative form of natural vi...lood in humans at levels determined to protect aga...rs naturally in eight different forms. The primary...ol, or TCP. But another natural form of vitamin E ...eated Ohio State University Medical Center studies...
...g smoking can improve lung function test scores by... The findings appear in the second issue for July ...itical Care Medicine, published by the American Th...Departments of Respiratory Medicine and Immunology...s studied 11 asthmatics who continued to smoke and...
...hildren under age 6 in Massachusetts over 22 years...n--especially infants--are now more likely to be o...of Ambulatory Care and Prevention of Harvard Medic...ars in the July issue of Obesity. , "The obesity e... children," says Matthew Gillman, MD, senior autho...
Other Biology News:Natural vitamin E tocotrienol reaches blood at protective levels 2Natural vitamin E tocotrienol reaches blood at protective levels 3Quitting smoking improves lung function considerably 2Today's babies are fatter babies 2
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...I and Endovascular Forum Launch Interactive, Case-...ide Learning and Collaboration , , LAS VEGAS, May...e complication, another physician has likely seen ...iovascular Angiography and Interventions (SCAI) an...es Company, today unveiled a new educational Websi...
...TTLE, May 6 Dendreon Corporation (Nasdaq: DNDN ...ed March 31, 2009. Revenue for the first quarter ...arter ended March 31, 2008. , , Dendreon,s tota...rch 31, 2009 were $17.0 million compared to $19.2 ... for the quarter ended March 31, 2009 was $15.4 mi...
...MBRIDGE, Mass. May 5, 2009 Researchers at the Ha...SEAS), in collaboration with researchers from Worc...ed, for the first time, that the activation energy...ted by the surrounding dielectric and can be modif.... , The finding, published in the April 6 issue o...
Other Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4Dendreon Reports First Quarter 2009 Financial Results 2Dendreon Reports First Quarter 2009 Financial Results 3Dendreon Reports First Quarter 2009 Financial Results 4Dendreon Reports First Quarter 2009 Financial Results 5Scientists demonstrate effect of confining dielectrics on semiconductor nanowire conductivity 2
pYES2 from Invitrogen
Nunc MicroWell Mini Trays from Invitrogen
Rabbit Anti-Human MTHFD1 Polyclonal Antibody, Unconjugated from Atlas Antibodies
GIBCO Improved MEM Zn++ Option (Richter's Modification) liquid from Invitrogen
Biology Products: